Author/Authors :
Sharifi-Mood ، B نويسنده Dept. of Infectious Diseases, School of Medicine, Zahedan University of Medical Sciences, Iran , , Alavi–Naini ، R نويسنده Dept. of Infectious Diseases, School of Medicine, Zahedan University of Medical Sciences, Iran , , Salehi ، M نويسنده Dept. of Infectious Diseases, School of Medicine, Zahedan University of Medical Sciences, Iran , , Kouhpayeh ، H نويسنده Dept. of Infectious Diseases, School of Medicine, Zahedan University of Medical Sciences, Iran , , Mokhtari-Azad ، T نويسنده Dept. of Virology, School of Health, Tehran University of Medical Sciences, Iran , , Nasser- Poor ، T نويسنده Dept. of Microbiology, School of Medicine, Zahedan University of Medical Sciences, Iran ,
Abstract :
Background: In Iran, despite the use of vaccine since 1976, we are still having local epidemics especially in
the children aged 15-20 years old. Since 1996, the yearly epidemics of measles have been reported in these
groups in Sistan- Baluchestan province, south east of Iran. The present study was conducted to determinate
the level of immunity in this target population in Zahedan.
Methods: A total of 375 school-aged children were selected randomly from 8 schools in four areas of Zahedan
city, Sistan-Baluchestan province, Iran, in 2000-1. Sera were separated in laboratory and examined for
measles antibody. The titers of antibody against measles were measured using hemaglutination inhibition
method. A titer of 1:4 or more was considered as positive and protective to measles.
Results: A total of 298 samples (76.8%) were positive at the titer 1:4 or more. Among 375 of total cases, 349
students (93%) were vaccinated twice and 26 cases (7%) were vaccinated once. Only 78.6% of the former
group was immune against measles and in the letter group, the titer of antibody was under the protective
level. No significant correlation was found between seropositivity and sex (P > 0.05).
Conclusion: It is concluded that the present vaccination program (at 9 and 15 months of age) for production
of immunity against measles in this area is insufficient. A new vaccination program (at the age of 12 months
and 4-6 years of age) can bring under control the measles by increasing level immunity.